"10.1371_journal.pone.0086671","plos one","2014-01-23T00:00:00Z","Toshihiro Okamoto; Satoshi Iwata; Hiroto Yamazaki; Ryo Hatano; Eriko Komiya; Nam H Dang; Kei Ohnuma; Chikao Morimoto","Department of Therapy Development and Innovation for Immune disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan; Division of Clinical Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Division of Hematology and Oncology, University of Florida Shands Cancer Center, Gainesville, Florida, United States of America","Conceived and designed the experiments: TO SI CM. Performed the experiments: TO SI EK RH. Analyzed the data: TO SI CM. Contributed reagents/materials/analysis tools: EK RH KO HY. Wrote the paper: TO SI CM ND.","C. Morimoto is a patent holder of humanized CD26 monoclonal antibody (name of patent: Anti-CD26 antibodies and Methods of use thereof. Number of patent: US Patent # 7402698). Ys therapeutics,Inc owns this patent and C. Morimoto is one of founders of this company. C. Morimoto declares that this does not alter the authors adherence to all PLOS ONE policies on sharing data and materials as detailed online in the guide for authors.","2014","01","Toshihiro Okamoto","TO",8,TRUE,3,4,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
